SEP 26, 2016 5:59 PM PDT

New Procedure for Post-Heart Attack Treatment Could Save Lives

WRITTEN BY: Kara Marker
From the mind of an aerospace engineer, not a cardiologist, comes a life-changing new device for treating individuals following a heart attack. The new technology, an advanced type of left ventricular assist device (LVAD), is projected to prolong tens of thousands of lives per year. 
The percutaneous heart pump developed at Penn State with a model of the left ventricle of a human heart
Robert Kunz, principal investigator and aerospace engineer at Penn State University, said that the new “Heartmate Percutaneous Heart Pump (PHP)” is the “first device that allows a cardiologist or technician to immediately stabilize someone who has had a serious heart attack.” For individuals suffering a heart attack, the sooner blood flow to the heart can be restored, the better.

During a heart attack, also known as myocardial infarction, a lack of blood flow to the heart causes permanent damage to the heart muscle, or the myocardium. A heart attack can be caused by coronary artery disease because individuals with this condition have arteries blocked by plaque buildup from atherosclerosis. When the artery becomes completely blocked, oxygen can no longer reach the heart, the heart stops functioning, and the entirety of the body is affected. The longer a heart attack isn’t addressed, the more damage is done to the body tissues due to a lack of oxygen.

The Heartmate PHP strengths heart muscle weakened by myocardial infarction by improving blood flow. The six-millimeter wide pump is inserted into the femoral artery and “threaded up” until it eventually reaches the left ventricle where it begins to improve blood flow. This technology is already approved in Europe and pending FDA approval in the United States. Kunz and his team of scientists have been working on the Heartmate PHP for over a decade.

Kunz said that the “pump is designed to be inserted, deployed, and operating within minutes of a patient suffering a heart attack,” an ability the satisfies the urgency of the situation. Existing LVAD technology is usually represented by a battery-operated mechanical pump inserted surgically to help the left ventricle, the main pumping chamber of the heart, pump blood to the rest of the body.

Traditional LVADs and the new Heartmate PHP serve to prevent invasive surgeries following heart attacks due to oxygen deficiencies and damage done to body tissues. However, these devices are also used to keep an individual alive while they wait for bypass surgery or even a heart transplant. Unfortunately, wait times for a heart transplant are often six months or longer, and patients waiting for a donor find themselves relying on their LVAD to keep them alive.

Pending approval from the FDA, the new Heartmate PHP has the potential to change many lives. While working on the device, Kurtz used the same methods and ideas that experts do while developing submarine and torpedo propellers. Thanks to a project that started back in 2004, individuals suffering heart attacks will have a much better chance at a full recovery.
 


Sources: Penn State University, Cleveland Clinic, Stanford Healthcare, UCSF Health
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
JUN 27, 2020
Cardiology
Automating the Analysis of the Circle of Willis to Determine Vascular Health
JUN 27, 2020
Automating the Analysis of the Circle of Willis to Determine Vascular Health
The Circle of Willis (CoW) is a vital part of the brain’s anatomy that acts as a junction of blood flow. It i ...
JUL 28, 2020
Cancer
Should you get your DNA test for community-based genetic screening?
JUL 28, 2020
Should you get your DNA test for community-based genetic screening?
In a new study published in the journal Nature Medicine, researchers champion the potential of community-based gene ...
AUG 01, 2020
Cardiology
Identifying Biomarkers for the Diagnosis of Diabetic Cardiomyopathy
AUG 01, 2020
Identifying Biomarkers for the Diagnosis of Diabetic Cardiomyopathy
Type 2 diabetes affects millions around the world.  By itself, it prevents your body from properly using sugars fro ...
SEP 10, 2020
Cardiology
Many Doctors Have Used the Wrong Criteria to Diagnose Hypertension
SEP 10, 2020
Many Doctors Have Used the Wrong Criteria to Diagnose Hypertension
A recent survey has shown that most health care professionals may not be using the current information to screen for and ...
SEP 22, 2020
Cardiology
Mosquito-Borne Illnesses are Linked to Stroke
SEP 22, 2020
Mosquito-Borne Illnesses are Linked to Stroke
Mosquitoes are major disease vectors; they are considered the world's deadliest animal because they kill so many people.
NOV 26, 2020
Cardiology
Possible Cardioprotective Effects of the Diabetes Drug Empagliflozin
NOV 26, 2020
Possible Cardioprotective Effects of the Diabetes Drug Empagliflozin
Cardiovascular disease and diabetes are often associated with each other, as many issues caused by diabetes promote hear ...
Loading Comments...